Open AccessLong‑term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor‑resistant gastroesophageal reflux diseaseOpen AccessAuthor(s)
Satoshi Shinozaki,
Hiroyuki Osawa,
Yoshikazu Hayashi,
Yoshimasa Mıura,
Alan Kawarai Lefor,
Hironori Yamamoto
Publication year2021
Publication title
biomedical reports
Resource typeJournals
PublisherSpandidos Publishing
Subject(s)constipation , diarrhea , disease , epigastric pain , gastroenterology , gerd , insulin , medicine , postprandial , proton pump inhibitor , reflux , vomiting
Language(s)English
SCImago Journal Rank0.607
H-Index25
eISSN2049-9442
pISSN2049-9434
DOI10.3892/br.2021.1408
Seeing content that should not be on Zendy? Contact us.